Dermal-Epidermal Junction

The epidermis has no blood supply of its own. Everything it needs crosses the dermal-epidermal junction, a thin layered membrane of collagen types IV and VII, laminins and anchoring fibrils that both feeds the epidermis and mechanically fastens it to the dermis below.

In young skin the junction is corrugated: dermal papillae push up into the epidermis, and the interlocking increases both the contact area for exchange and the resistance to shear. With age and with accumulated ultraviolet exposure it flattens. Less interlocking means a smaller exchange surface, more fragile attachment and skin that bruises, tears and blisters more readily — visible in the way older skin behaves under adhesive tape.

The flattening is now a standard target in anti-ageing research and in ingredient marketing, which are not the same activity. Laboratory work on skin explants and on cultured cells reports increased synthesis of junction components with several ingredients; demonstrating that a finished product restores junction architecture in a living person is a much harder study and is rarely done.

What is well supported is the same short list as always: avoiding further ultraviolet damage, and retinoids, which have human evidence for improving the dermal side of the equation. Anything claiming to rebuild this specific structure deserves the question of what was measured, in whom, and by whom.